A002210 Stock Overview
Manufactures and sells pharmaceuticals and cosmetics in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Dong Sung Bio Pharm.Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,155.00 |
| 52 Week High | ₩5,950.00 |
| 52 Week Low | ₩4,150.00 |
| Beta | 0 |
| 1 Month Change | -21.90% |
| 3 Month Change | -9.08% |
| 1 Year Change | -26.07% |
| 3 Year Change | -48.96% |
| 5 Year Change | -73.54% |
| Change since IPO | 5.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| A002210 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -6.4% | -2.3% | 0.3% |
| 1Y | -26.1% | 11.7% | -1.5% |
Return vs Industry: A002210 underperformed the KR Pharmaceuticals industry which returned 11.7% over the past year.
Return vs Market: A002210 underperformed the KR Market which returned -1.5% over the past year.
Price Volatility
| A002210 volatility | |
|---|---|
| A002210 Average Weekly Movement | 4.7% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A002210 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A002210's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | n/a | Yang-Gu Lee | dongsung-pharm.com |
Dong Sung Bio Pharm.Co.,Ltd. manufactures and sells pharmaceuticals and cosmetics in South Korea. The company offers over the counter drugs, such as emollient, vitamin supplement, alopecia treatment, antihistamines, liver disease treatment, fire extinguisher solvent, antiviral, eye drops, menopause treatment, sleep inducer, antipyretic, analgesic, anti-inflammatory, vascular reinforcement, broad-spectrum skin disease treatment, gum disease treatment, blood circulation improver, scar treatment, dry stomach, eye nourishment, abdominal obesity treatment, anti-soil agent, respiratory solvent, and antifungal agent.
Dong Sung Bio Pharm.Co.,Ltd. Fundamentals Summary
| A002210 fundamental statistics | |
|---|---|
| Market cap | ₩95.01b |
| Earnings (TTM) | ₩1.70b |
| Revenue (TTM) | ₩78.44b |
0.0x
P/E Ratio0.0x
P/S RatioIs A002210 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A002210 income statement (TTM) | |
|---|---|
| Revenue | ₩78.44b |
| Cost of Revenue | ₩33.23b |
| Gross Profit | ₩45.21b |
| Other Expenses | ₩43.51b |
| Earnings | ₩1.70b |
Last Reported Earnings
Dec 31, 2011
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A002210 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/18 23:12 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2011/12/31 |
| Annual Earnings | 2011/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dong Sung Bio Pharm.Co.,Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sang-Hun Lee | iM Securities |
| Choongwoo Seo | SK Securities Co., Ltd. |
| sangyun Lee | Yuanta Securities Korea Co., Ltd. |